The proposal to extend clinical trials, which are routinely used as systematic tests of pharmaceutical innovations, to new surgical procedures should not be implemented. The point is that surgical procedures differ in one important respect from medicinal drugs: a correctly prescribed drug depends for its effectiveness only on the drug’s composition, whereas transparently related to the skills of the surgeon who uses it.
What this question is testing
Conclusion
The author wants to block clinical trials for new surgical procedures.
Evidence
The reason: surgery effectiveness depends on the surgeon. Drug effectiveness doesn't — it's all about the chemistry.
Evaluate
The author treats clinical trials as if they only measure effectiveness. But trials do more than that. They also detect harm — whether a procedure is intrinsically dangerous or worse than existing options.
And the surgeon-skill issue doesn't cancel out harm detection. Even with skill variation, if a procedure is fundamentally bad, a trial can show it. So the author's reason against trials doesn't actually rule out one important reason for them.
Goal
Find the answer that calls out this overlooked use of trials — detecting intrinsic harm.
Reading along? Open the full official question in LawHub — we show a fragment here and keep the reasoning in our own words.